Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.01
+0.02 (0.40%)
At close: Oct 29, 2025, 4:00 PM EDT
4.990
-0.020 (-0.40%)
Pre-market: Oct 30, 2025, 8:46 AM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
Adeno-Associated Viruses-based Gene Therapies
15.45M
Log In
Adeno-Associated Viruses-based Gene Therapies Growth
517.55%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
United States
15.45M
Log In
United States Growth
517.55%
Log In